Biotech

All Articles

OS Therapies refiles $6M IPO to money HER2 medicine, preclinical ADCs

.OS Therapies will definitely list on the NYSE American supply substitution this morning using a $6....

ALX's waning CD47 response price sends sell spiraling down

.ALX Oncology's phase 2 gastric cancer reaction rate has actually compromised. After seeing its CD47...

Ionis axes eye condition coming from intendeds of Roche-partnered possibility after records dissatisfy

.Another of Ionis Pharmaceuticals' essential midphase readouts has actually disappointed assumptions...

Biogen's CEO said no dangerous handle 2023. He's ready to be strong

.While Biogen's pharma peers are actually searching for late-stage possessions along with little bit...

Instil refills pipeline in $2B biobucks cope with ImmunOnco

.Instil Biography has actually been actually a biotech trying to find a pipeline after it ditched it...

Biogen bows out Denali Alzheimer's collab

.Biogen has returned legal rights to an early Alzheimer's illness course to Denali Rehabs, going out...

Takeda faucets new head people oncology company-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of notable management hirings, shootings and...

Vertex, hammered by AATD once again, drops 2 properties on discard pile

.Tip's effort to manage an unusual hereditary health condition has struck yet another misfortune. Th...

Vir increases 3 T-cell engagers coming from Sanofi, lays off 25% of team

.Vir Medical's second-quarter earnings report had not been short of big news. The firm invited a tri...

Galapagos stops CAR-T tissue therapy litigation over Parkinsonism situation

.Galapagos has actually stopped briefly application in a trial of a BCMA-directed CAR-T cell treatme...